Blvr Valves denied due to quantity / dose limits by Humana?
Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for blvr valves are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Blvr Valves
## Why Humana Limits the Number of Bronchoscopic Lung Volume Reduction Valves — and Why You Can Appeal
Bronchoscopic lung volume reduction (BLVR) using one-way endobronchial valves is a minimally invasive procedure for patients with severe emphysema whose disease remains debilitating despite maximum medical therapy. Humana's quantity-limit policy restricts how many valves may be implanted in a single procedure or benefit period. Denials under this category typically occur when the treating bronchoscopist requests a quantity that exceeds Humana's coverage threshold or when a second staged procedure is planned.
These denials are appealable. The number of valves required is a clinical determination based on the anatomy of the targeted lobe, not an arbitrary choice. When the prescribing physician documents that the requested quantity is medically necessary to achieve adequate lobar occlusion, quantity-limit denials frequently reverse on appeal.
## Federal Appeal Framework
Your appeal rights depend on your plan type. Under the ACA (§2719), most non-grandfathered individual and group plans must offer internal appeal followed by independent external review. Under ERISA (§503), employer self-funded plans must provide a full-and-fair review. The external review window is generally open for roughly four months after the final internal denial. If your condition is worsening rapidly, request an expedited review, which must be decided within 72 hours.
## Concrete Appeal Steps and Timeline
1. Request the denial letter and Humana's published coverage/medical policy for BLVR valves in writing. The policy will state the exact quantity threshold you must address. 2. File the Level 1 internal appeal within the deadline printed on your denial notice (commonly 180 days). 3. If Level 1 fails, file a Level 2 appeal or proceed directly to independent external review. 4. External review is conducted by an Independent Review Organization (IRO) with no financial ties to Humana.
## Documentation to Gather
- Diagnosis confirmation: pulmonary function test reports, CT chest with fissure-integrity analysis, and HRCT imaging showing the target lobe distribution
- Prior treatment history: documentation of inhaled bronchodilator and corticosteroid regimens, pulmonary rehabilitation completion, and outcomes from each
- Clinical severity: most recent spirometry, diffusing capacity, exercise tolerance (e.g., 6-minute walk), and quality-of-life scores from your chart
- Procedural justification: bronchoscopy report or pre-procedure planning note from the interventional pulmonologist explaining why the specific quantity of valves is required for complete lobar exclusion
- Prescriber medical-necessity letter explicitly addressing Humana's quantity criteria
## Criteria-Mapping Structure
Pull every requirement listed in Humana's published BLVR coverage policy. For each requirement, record the exact supporting fact from your chart:
| Humana Policy Requirement | Chart Evidence Supporting Your Case | |---|---| | Diagnosis of severe emphysema confirmed by imaging | [CT report date and finding] | | Adequate fissure integrity on imaging analysis | [Fissure-analysis report and result] | | Completion of pulmonary rehabilitation | [Dates and program name] | | Optimized medical therapy | [Current medication list and duration] | | Quantity of valves consistent with target lobe anatomy | [Procedural planning note] |
Present this table in your appeal letter so the reviewer can match each policy requirement to a specific piece of documentation without hunting through the file.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →